Professor and Division Chief of Diabetes Division at the University of Texas Health Science Center
Deputy Director of Texas Diabetes Institute
Led the U.S. development of metformin, and FDA approval in 1995
Discovered a new approach to diabetes treatment that targets glucose reabsorption in the kidneys, which led to the development and approval of SGLT-2
Received several prestigious awards, including the Lilly Award (1987) by the American Diabetes Association, Banting Lectureship Award (1988) by the Canadian Diabetes Association, Novartis Award (2003), ADA’s Albert Renold Award (2002), the ADA’s Banting Award (2008), and the Harold Hamm International Prize (2018)
Published over 800 articles in peer-reviewed medical journals